Several Pharmacy Colleges in Maha Cut Short DPharm Course to 5 Months Amid PCI Approval Delays

Written By :  Parthika Patel
Published On 2025-11-06 09:39 GMT   |   Update On 2025-11-06 09:39 GMT
Advertisement

Pune: The first-year Diploma in Pharmacy (DPharm) programme has been reduced to a five-month session this year after the Pharmacy Council of India (PCI) delayed approvals for several colleges. This delay has forced institutions to compress what is typically a 10 to 11-month academic schedule into a shorter and more intensive format.

As per the Maharashtra State Board of Technical Education (MSBTE), the first-year academic session will now be conducted from October 2025 to April 18, 2026, with annual examinations beginning on April 30, 2026. The revised calendar has sparked concerns among educators and students about managing the full syllabus within such a limited timeframe.

Advertisement

To streamline the schedule, the board has mandated three internal examinations—from December 15 to 19, February 9 to 14, and April 6 to 10—followed by practice exams between April 20 and 25. However, with minimal breaks and a packed curriculum, students are expected to cope with a far more demanding academic load than usual.

Faculty members have voiced apprehensions over the possible impact on teaching quality and practical training.

According to a recent media report by the Hindustan Times, several colleges have started adopting crash-course formats and extended hours to ensure students can complete the syllabus before final exams.

Tags:    
Article Source : with inputs

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News